Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)
Price and Volume
Detailed Quote| Volume | 2,353,539 |
| Open | 32.66 |
| Bid (Size) | 30.03 (700) |
| Ask (Size) | 30.09 (400) |
| Prev. Close | 32.52 |
| Today's Range | 29.91 - 32.66 |
| 52wk Range | 18.92 - 43.15 |
| Shares Outstanding | 99,581,693 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
3 Companies at the Forefront of the GLP-1 Pill Wars ↗
March 16, 2026
The Valuation Reset: A Deep-Dive into Novo Nordisk (NVO) in 2026
February 27, 2026
Viking Therapeutics: The High-Stakes Weight Loss Contender ↗
February 26, 2026
Why Viking Therapeutics Stock Is Up More Than 9% Today ↗
February 23, 2026
Is Viking Therapeutics Stock Really Going to $125? ↗
February 19, 2026
Frequently Asked Questions
Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 30.06
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 03/30/26 03:24 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.99B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube